The Royal Marsden NHS Foundation TrustLondon, England, United Kingdom
Paper 62 - DATA DRIVEN MODELLING OF SPATIAL HETEROGENEITY IN SOFT TISSUE SARCOMAS IDENTIFIES PROGNOSTIC GROUPS FOLLOWING NEOADJUVANT CHEMOTHERAPY: ANALYSIS OF THE ISG-STS-1001 TRIAL
Saturday, November 15, 20259:00 AM - 10:30 AM EST
Disclosure information not submitted.